Standard Biotools (LAB) Enterprise Value Growth (5y) (2015 - 2026)
Standard Biotools (LAB) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Standard Biotools | 254.35 Mn | -222.37 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -242.20% |
| Mar 31, 2026 | -55.07% |
| Dec 31, 2025 | -21.95% |
| Sep 30, 2025 | -21.58% |
| Jun 30, 2025 | -38.53% |
| Mar 31, 2025 | -39.38% |
| Dec 31, 2024 | -37.18% |
| Sep 30, 2024 | -41.49% |
| Jun 30, 2024 | -41.05% |
| Mar 31, 2024 | -43.90% |
| Dec 31, 2023 | -3.93% |
| Sep 30, 2023 | -29.33% |
| Jun 30, 2023 | -28.77% |
| Mar 31, 2023 | -26.87% |
| Dec 31, 2022 | -21.45% |
| Sep 30, 2022 | -24.45% |
| Jun 30, 2022 | -38.24% |
| Mar 31, 2022 | 9.22% |
| Dec 31, 2021 | 13.09% |
| Sep 30, 2021 | 15.70% |